Cross Shawn
SEC CIK 1734779 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCRX | Pacira BioSciences, Inc. | CFO | 118.3K | — | $1.52M | 10 | 2024-11-01 | 2026-04-23 |
Most active insiders at PCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cross Shawn | CFO | — | $1.52M |
| 2 | WILLIAMS KRISTEN | Chief Administrative Off | — | $498.2K |
| 3 | RIKER LAUREN | SVP, Fin | — | $261.3K |
| 4 | SLONIN JONATHAN | Chief Medical Off | — | $240.4K |
| 5 | Froimson Mark | Dir | — | $10.9K |
| 6 | BIGAL MARCELO | Dir | — | — |
| 7 | Young Alethia | Dir | — | — |
| 8 | Teehan Brendan | Chief Commercial Off | — | — |
| 9 | Lee Frank D. | CEO, Dir | — | — |
| 10 | CHRISTIE CHRISTOPHER | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-24 20:41 | 2026-04-23 | PCRX | Pacira BioSciences, Inc. | Cross Shawn | CFO | M - OptEx | $16.45 | +12.9K | 118.3K | +12% | +$212.9K |
| DT | 2026-04-24 20:41 | 2026-04-23 | PCRX | Pacira BioSciences, Inc. | Cross Shawn | CFO | S - Sale+OE | $25.16 | -12.9K | 105.3K | -11% | -$325.6K |
| DMT | 2026-04-22 20:03 | 2026-04-20+ | PCRX | Pacira BioSciences, Inc. | Cross Shawn | CFO | M - OptEx | $16.45 | +12.1K | 106.8K | +13% | +$198.4K |
| DMT | 2026-04-22 20:03 | 2026-04-20+ | PCRX | Pacira BioSciences, Inc. | Cross Shawn | CFO | S - Sale+OE | $25.09 | -12.1K | 105.3K | -10% | -$302.6K |
| 2026-02-13 | 2026-02-11 | PCRX | Pacira BioSciences, Inc. | Cross Shawn | CFO | A - Grant | $0.00 | +49.1K | 105.3K | +87% | $0 | |
| DM | 2025-12-11 | 2025-12-09+ | PCRX | Pacira BioSciences, Inc. | Cross Shawn | CFO | M - OptEx | $16.45 | +25.0K | 72.1K | +53% | +$411.2K |
| DM | 2025-12-11 | 2025-12-09+ | PCRX | Pacira BioSciences, Inc. | Cross Shawn | CFO | S - Sale+OE | $25.07 | -25.0K | 56.2K | -31% | -$626.8K |
| 2025-11-13 | 2025-11-10 | PCRX | Pacira BioSciences, Inc. | Cross Shawn | CFO | S - Sale | $22.09 | -12.1K | 56.2K | -18% | -$266.4K | |
| 2025-11-03 | 2025-10-31 | PCRX | Pacira BioSciences, Inc. | Cross Shawn | CFO | F - Tax | $21.38 | -6,690 | 68.3K | -9% | -$143.0K | |
| D | 2024-11-05 | 2024-11-01 | PCRX | Pacira BioSciences, Inc. | Cross Shawn | CFO | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations